IL-2 mutein promotes antigen-specific transplant acceptance in mice through expansion of ST2+ reg...

IL-2 mutein promotes antigen-specific transplant acceptance in mice through expansion of ST2+ regulatory T cells  Nature

Korea. IL2 Series - Official VR Trailer | VR Games Showcase Summer 2026 - IGN India

Korea. IL2 Series - Official VR Trailer | VR Games Showcase Summer 2026  IGN India

Yankees activate Austin Wells from IL after 2-week absence - ESPN

Yankees activate Austin Wells from IL after 2-week absence  ESPN

Targeting the IL-2 Pathway to Overcome Immunotherapy Resistance in Melanoma - Targeted Oncology

Targeting the IL-2 Pathway to Overcome Immunotherapy Resistance in Melanoma  Targeted Oncology

Why a Russian Developer Focused on the Korean War: "The Last Great Air War That Defined an Era" -...

Why a Russian Developer Focused on the Korean War: "The Last Great Air War That Defined an Era"  Inven Global

Single-Dose IL-2 Fusion Protein Shows Hair Regrowth Signal in Early Trial - Dermatology Times

Single-Dose IL-2 Fusion Protein Shows Hair Regrowth Signal in Early Trial  Dermatology Times

Tornado killing 2 in Jefferson County, IL rated EF3 by the National Weather Service - First Alert 4

Tornado killing 2 in Jefferson County, IL rated EF3 by the National Weather Service  First Alert 4

Ascendis axes IL-2 program in retreat from oncology expansion - Fierce Biotech

Ascendis axes IL-2 program in retreat from oncology expansion  Fierce Biotech

2 Killed After Tornado Touches Down In Jefferson County - Patch

2 Killed After Tornado Touches Down In Jefferson County  Patch

At least 2 killed in IL tornado - WKRN News 2

At least 2 killed in IL tornado  WKRN News 2

Maintenance results boost Nektar's case for IL-2 agonist in atopic dermatitis - FirstWord Pharma

Maintenance results boost Nektar's case for IL-2 agonist in atopic dermatitis  FirstWord Pharma

IL-2 Korea: Preview - Key Aero

IL-2 Korea: Preview  Key Aero

Facile induction of immune tolerance by an interleukin-2–TGFβ surrogate agonist - Nature

Facile induction of immune tolerance by an interleukin-2–TGFβ surrogate agonist  Nature

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 tr...

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial  Nature

T cell effector function by potentiating glucose metabolism and IL-2 signaling - Nature

T cell effector function by potentiating glucose metabolism and IL-2 signaling  Nature

Efficacy and safety of low-dose interleukin 2 for Behçet’s syndrome: a randomized, placebo-contro...

Efficacy and safety of low-dose interleukin 2 for Behçet’s syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trial  Nature

αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility ...

αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility in mouse models  Nature

An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights a...

An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights and evaluation of mitigation strategies  Nature

IL2Pepscan: A machine learning framework for predicting IL-2 inducing peptides and their identifi...

IL2Pepscan: A machine learning framework for predicting IL-2 inducing peptides and their identification across global viral proteomes  Nature

Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes - Nature

Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes  Nature

AVB-001 Encapsulated IL-2 Cell Therapy Shows Safety and Immune Activity in Platinum-Resistant HGS...

AVB-001 Encapsulated IL-2 Cell Therapy Shows Safety and Immune Activity in Platinum-Resistant HGSOC  OncLive

First-in-Class IL-2 Pathway Agonist Advances in AD - Dermatology Times

First-in-Class IL-2 Pathway Agonist Advances in AD  Dermatology Times

Aulos looks to Phase III for IL-2 mAb in NSCLC and melanoma - Clinical Trials Arena

Aulos looks to Phase III for IL-2 mAb in NSCLC and melanoma  Clinical Trials Arena

Navigating the IL-2 Experience - Cure Today

Navigating the IL-2 Experience  Cure Today

Cross-Compartment Multimodal Analyses Reveal Differences in IL2-STAT5 Signaling Associated With A...

Cross-Compartment Multimodal Analyses Reveal Differences in IL2-STAT5 Signaling Associated With Asthma in Individuals From Diverse Backgrounds  Wiley Online Library

New Korean War Flight Simulator: 'IL-2 Sturmovik: Korea' - Inven Global

New Korean War Flight Simulator: 'IL-2 Sturmovik: Korea'  Inven Global

FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC - CancerNetwork

FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC  CancerNetwork

Immunology & Cell Biology | ASI Journal - Wiley Online Library

Immunology & Cell Biology | ASI Journal  Wiley Online Library

BLIMP1 negatively regulates IL-2 signaling in T cells - Science | AAAS

BLIMP1 negatively regulates IL-2 signaling in T cells  Science | AAAS

[ESMO 2025] GI Innovation’s IL-2 therapy shows tumor response in ICB-resistant cancers - koreabio...

[ESMO 2025] GI Innovation’s IL-2 therapy shows tumor response in ICB-resistant cancers  koreabiomed.com

Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation...

Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2  Nature

Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and...

Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells | PLOS One  PLOS

Anti–PD-1–resistant melanoma: IL-2–free TIL therapy prolongs PFS vs chemotherapy - Vera Health

Anti–PD-1–resistant melanoma: IL-2–free TIL therapy prolongs PFS vs chemotherapy  Vera Health

In Silico tool for predicting, designing and scanning IL-2 inducing peptides | Scientific Reports...

In Silico tool for predicting, designing and scanning IL-2 inducing peptides | Scientific Reports  Nature

iLeukon Receives FDA Clearance of IND Application for A Phase II Study of mRNA-based non-alpha IL...

iLeukon Receives FDA Clearance of IND Application for A Phase II Study of mRNA-based non-alpha IL-2 variant, ILKN421H, in Advanced Non-Small Cell Lung Cancer (NSCLC)  PR Newswire

Three essential biomarkers for measuring immune activation - News-Medical

Three essential biomarkers for measuring immune activation  News-Medical

IDOT adding binoculars to IL-2 viewing area for Chief Black Hawk Statue - WREX

IDOT adding binoculars to IL-2 viewing area for Chief Black Hawk Statue  WREX

Korea Flight Sim Declares War on Eternal Early Access - DualShockers

Korea Flight Sim Declares War on Eternal Early Access  DualShockers

Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics - Science | AAAS

Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics  Science | AAAS

First-in-Human Trial Evaluated Implantable IL‑2 Cell Therapy in Ovarian Cancer - Technology Networks

First-in-Human Trial Evaluated Implantable IL‑2 Cell Therapy in Ovarian Cancer  Technology Networks

Korea. IL-2 Series - Official Early Access Release Date Trailer - IGN India

Korea. IL-2 Series - Official Early Access Release Date Trailer  IGN India

CPI-refractory cutaneous melanoma: Imneskibart plus low-dose IL-2 shows early disease control - V...

CPI-refractory cutaneous melanoma: Imneskibart plus low-dose IL-2 shows early disease control  Vera Health

1C Game Studios Presents "Korea. IL-2 Series" and Talks About the Future of the Series - ixbt.games

1C Game Studios Presents "Korea. IL-2 Series" and Talks About the Future of the Series  ixbt.games

Flight Sim Il-2 Korea Release Date Hits the Peninsula Before Modern Warfare 4 - DualShockers

Flight Sim Il-2 Korea Release Date Hits the Peninsula Before Modern Warfare 4  DualShockers

Omid Veiseh: First-in-Human Clinical Trial of IL-2 Cytokine Factories in Refractory Ovarian Cance...

Omid Veiseh: First-in-Human Clinical Trial of IL-2 Cytokine Factories in Refractory Ovarian Cancer  Oncodaily

Korea: IL-2 Series Preview and New Gameplay – A Promising Window Into the Early Jet Age - Simulat...

Korea: IL-2 Series Preview and New Gameplay – A Promising Window Into the Early Jet Age  Simulation Daily

Korean War Flight Simulator Korea: IL-2 Series Reveals Its Detailed Airfields - Simulation Daily

Korean War Flight Simulator Korea: IL-2 Series Reveals Its Detailed Airfields  Simulation Daily

Korea. IL-2 Series Reveals Post-Launch Content Roadmap - Bleeding Cool News

Korea. IL-2 Series Reveals Post-Launch Content Roadmap  Bleeding Cool News

Developers of "Korea. Il-2 Series" Showed a Spectacular Trailer and Postponed the Release - ixbt....

Developers of "Korea. Il-2 Series" Showed a Spectacular Trailer and Postponed the Release  ixbt.games

Takeda pays Innovent $1.2B upfront, offers whopping $10B-plus in biobucks for cancer assets - Fie...

Takeda pays Innovent $1.2B upfront, offers whopping $10B-plus in biobucks for cancer assets  Fierce Biotech

Il-2-Building-a-tank killer - HistoryNet

Il-2-Building-a-tank killer  HistoryNet

New Flight Sim Wants You Broke To Get Above Minimum Spec - DualShockers

New Flight Sim Wants You Broke To Get Above Minimum Spec  DualShockers

Korean War Flight Simulator Korea: IL-2 Series Reveals Exams Mode - Simulation Daily

Korean War Flight Simulator Korea: IL-2 Series Reveals Exams Mode  Simulation Daily

Korea. IL-2 Series Releases New Gameplay Trailer - Bleeding Cool News

Korea. IL-2 Series Releases New Gameplay Trailer  Bleeding Cool News

Korea. IL-2 Series - IGN Africa

Korea. IL-2 Series  IGN Africa

Reprogramming Immunity to Treat ALS - the-scientist.com

Reprogramming Immunity to Treat ALS  the-scientist.com

New trial to test effectiveness of COYA 302 to slow ALS progression - ALS News Today

New trial to test effectiveness of COYA 302 to slow ALS progression  ALS News Today

Nektar touts 'deepening clinical effect' of IL-2 agonist in atopic dermatitis - FirstWord Pharma

Nektar touts 'deepening clinical effect' of IL-2 agonist in atopic dermatitis  FirstWord Pharma

Korea: IL-2 Series Coming to Steam, Reveals Post-Launch Roadmap - Simulation Daily

Korea: IL-2 Series Coming to Steam, Reveals Post-Launch Roadmap  Simulation Daily

Developers of "Koreya. Il-2 Game Series" Announce Early Access Release Date - Present Interface a...

Developers of "Koreya. Il-2 Game Series" Announce Early Access Release Date - Present Interface and New Air Combat Simulator Trailer  ixbt.games

Korean War Flight Simulator Korea: IL-2 Series Reveals Its Impressive Clouds - Simulation Daily

Korean War Flight Simulator Korea: IL-2 Series Reveals Its Impressive Clouds  Simulation Daily

Flight sim "Korea. IL-2 series" developers dived to the ground and showed local residents - ixbt....

Flight sim "Korea. IL-2 series" developers dived to the ground and showed local residents  ixbt.games

IL-2 based cancer immunotherapies: an evolving paradigm - Frontiers

IL-2 based cancer immunotherapies: an evolving paradigm  Frontiers

Korean War Flight Simulator Korea: IL-2 Series Lands on Steam With New Page - Simulation Daily

Korean War Flight Simulator Korea: IL-2 Series Lands on Steam With New Page  Simulation Daily

Korea. IL-2 Series - Official Pre-Order Trailer - IGN

Korea. IL-2 Series - Official Pre-Order Trailer  IGN

Korea: IL-2 Series Reveals Gun and Cannon Effects - Simulation Daily

Korea: IL-2 Series Reveals Gun and Cannon Effects  Simulation Daily

Low-Dose IL-2 Shows Promise in Early Alzheimer’s Trial - EMJ

Low-Dose IL-2 Shows Promise in Early Alzheimer’s Trial  EMJ

PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function - Nature

PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function  Nature

Engineering IL-2 for immunotherapy of autoimmunity and cancer - Nature

Engineering IL-2 for immunotherapy of autoimmunity and cancer  Nature

Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective ...

Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective and emerging trends  Nature

Cubs Place Catcher Miguel Amaya on the 10-day IL, 2 Days After Activating Him - FOX Sports

Cubs Place Catcher Miguel Amaya on the 10-day IL, 2 Days After Activating Him  FOX Sports

Exams to appear in the flight simulator "Korea. Il-2 Game Series" - developers expanded the train...

Exams to appear in the flight simulator "Korea. Il-2 Game Series" - developers expanded the training system  ixbt.games

Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor ...

Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor  PNAS

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy -...

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy  Nature

PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program - Nature

PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program  Nature

Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells - Nature

Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells  Nature

A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals - ...

A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals  Science | AAAS

An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammat...

An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma  Nature

Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue...

Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue  Nature

Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and...

Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity  Nature

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8 - Nature

A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8  Nature

Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates ...

Targeting tumor microenvironment with antibody-guided IL-2 pro-cytokine promotes and rejuvenates dysfunctional CD8  Nature

A single-agent fusion of human IL-2 and anti-IL-2 antibody that selectively expands regulatory T ...

A single-agent fusion of human IL-2 and anti-IL-2 antibody that selectively expands regulatory T cells  Nature

Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulator...

Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation  Nature

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy - Nature

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy  Nature

CD301b+ dendritic cell-derived IL-2 dictates CD4+ T helper cell differentiation - Nature

CD301b+ dendritic cell-derived IL-2 dictates CD4+ T helper cell differentiation  Nature

Korea. IL-2 Series - IGN India

Korea. IL-2 Series  IGN India

An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism - Nature

An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism  Nature

Managing Toxicities of High-Dose Interleukin-2 - CancerNetwork

Managing Toxicities of High-Dose Interleukin-2  CancerNetwork

Effects of interleukin-2 in immunostimulation and immunosuppression - Rockefeller University Press

Effects of interleukin-2 in immunostimulation and immunosuppression  Rockefeller University Press

Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2 - Na...

Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2  Nature

Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune respons...

Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response  Nature

IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8 - Nature

IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8  Nature

Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficac...

Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models  Nature

De novo design of potent and selective mimics of IL-2 and IL-15 - Nature

De novo design of potent and selective mimics of IL-2 and IL-15  Nature

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, dou...

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial  The Lancet

A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo ...

A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells  Nature

Adding low-dose IL-2 to riluzole may improve survival in ALS - ALS News Today

Adding low-dose IL-2 to riluzole may improve survival in ALS  ALS News Today

IL-2 treatment can be dangerous. Here’s how drug firms are trying to fix it - C&EN

IL-2 treatment can be dangerous. Here’s how drug firms are trying to fix it  C&EN

Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People wi...

Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People with Systemic Lupus Erythematosus  Lupus Foundation of America